Maryland State Retirement & Pension System raised its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 7.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,190 shares of the company’s stock after acquiring an additional 527 shares during the quarter. Maryland State Retirement & Pension System’s holdings in McKesson were worth $6,139,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Ritholtz Wealth Management lifted its holdings in McKesson by 6.3% in the 3rd quarter. Ritholtz Wealth Management now owns 14,918 shares of the company’s stock worth $12,737,000 after purchasing an additional 887 shares in the last quarter. UNIVEST FINANCIAL Corp grew its holdings in McKesson by 4.3% during the 3rd quarter. UNIVEST FINANCIAL Corp now owns 675 shares of the company’s stock valued at $576,000 after buying an additional 28 shares in the last quarter. DSG Capital Advisors LLC grew its holdings in McKesson by 20.0% during the 3rd quarter. DSG Capital Advisors LLC now owns 4,134 shares of the company’s stock valued at $3,530,000 after buying an additional 690 shares in the last quarter. Northbridge Financial Group LLC grew its holdings in McKesson by 2.1% during the 3rd quarter. Northbridge Financial Group LLC now owns 766 shares of the company’s stock valued at $706,000 after buying an additional 16 shares in the last quarter. Finally, AMG National Trust Bank raised its position in shares of McKesson by 2.0% during the third quarter. AMG National Trust Bank now owns 3,596 shares of the company’s stock valued at $3,071,000 after buying an additional 69 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
McKesson Stock Performance
NYSE:MCK opened at $1,076.26 on Friday. The stock’s fifty day moving average is $951.81 and its 200 day moving average is $873.19. The firm has a market capitalization of $124.27 billion, a PE ratio of 27.67, a PEG ratio of 1.82 and a beta of 0.27. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,121.50.
McKesson Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be paid a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s payout ratio is currently 9.67%.
Insider Transactions at McKesson
In other McKesson news, CAO B Jr sold 111 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $995.80, for a total value of $796,640.00. Following the completion of the transaction, the executive vice president directly owned 5,423 shares in the company, valued at approximately $5,400,223.40. This trade represents a 12.86% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161 shares of company stock worth $2,242,515 over the last 90 days. Insiders own 0.06% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the stock. UBS Group boosted their target price on shares of McKesson from $1,200.00 to $1,250.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Argus raised their target price on shares of McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. JPMorgan Chase & Co. lifted their price target on shares of McKesson from $1,042.00 to $1,255.00 and gave the company an “overweight” rating in a report on Tuesday. TD Cowen lifted their price target on shares of McKesson from $1,006.00 to $1,200.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Finally, Citigroup boosted their price target on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $1,040.29.
Read Our Latest Research Report on McKesson
McKesson Company Profile
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.
Recommended Stories
- Five stocks we like better than McKesson
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
